Literature DB >> 17203175

The expression of low density lipoprotein receptor-related protein in colorectal carcinoma.

Katrin Obermeyer1, Sabine Krueger, Brigitte Peters, Bernd Falkenberg, Albert Roessner, Christoph Röcken.   

Abstract

Low density lipoprotein receptor-related protein (LRP) is a multifunctional cell surface receptor binding many different ligands including proteinases and their inhibitors, some of which are known to be involved in tumor biology. We studied the expression of LRP and its putative role in colorectal carcinoma. Tissue samples were obtained from 50 patients with colorectal carcinoma and fixed in formalin and embedded in paraffin. Immunohistochemical staining was performed using antibodies directed against LRP, cathepsin B and urokinase-type plasminogen activator (u-PA). The expression of LRP was further studied by polymerase chain reaction. The TNM stage was determined according to UICC guide lines and was based upon histological analysis. LRP was primarily expressed in stroma cells [36 patients (72%)] and less frequently in tumor cells [6 patients (12%)]. In 22% of all cases LRP was prominent at the invasion front. Cathepsin B was found both in the tumor stroma [50 (100%)] and in the tumor cells [46 (92%)]. u-PA was present in the tumor stroma [44 (88%)] and in the tumor cells [44 (88%)]. In stromal cells the expression of LRP correlated significantly with the expression of u-PA (p=0.043). Furthermore, the expression of LRP and of u-PA in tumor cells correlated with the tumor stage according to UICC (p=0.038 and 0.018, respectively). We provide evidence that LRP is expressed in colorectal cancer. As LRP forms complexes with u-PA and its inhibitor, we suspect that LRP can influence the known effects of u-PA on tumor biology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17203175

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  11 in total

1.  LRP-1--CD44, a new cell surface complex regulating tumor cell adhesion.

Authors:  Gwenn Perrot; Benoit Langlois; Jérôme Devy; Albin Jeanne; Laurie Verzeaux; Sébastien Almagro; Hervé Sartelet; Cathy Hachet; Christophe Schneider; Emilie Sick; Marion David; Michel Khrestchatisky; Hervé Emonard; Laurent Martiny; Stéphane Dedieu
Journal:  Mol Cell Biol       Date:  2012-06-18       Impact factor: 4.272

2.  Pro-cathepsin D interacts with the extracellular domain of the beta chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth.

Authors:  Mélanie Beaujouin; Christine Prébois; Danielle Derocq; Valérie Laurent-Matha; Olivier Masson; Sophie Pattingre; Peter Coopman; Nadir Bettache; Jami Grossfield; Robert E Hollingsworth; Hongyu Zhang; Zemin Yao; Bradley T Hyman; Peter van der Geer; Gary K Smith; Emmanuelle Liaudet-Coopman
Journal:  J Cell Sci       Date:  2010-09-07       Impact factor: 5.285

3.  Multimodal Approach for Cancer Cell Investigation.

Authors:  Alexandre Berquand; Jerôme Devy
Journal:  Methods Mol Biol       Date:  2021

4.  Significance of LRP and PPAR-gamma Expression in Lipomatous Soft Tissue Tumors.

Authors:  Takashi Tajima; Takeshi Morii; Fumihito Kikuchi; Akihiko Matsumine; Hiroaki Murata; Hiroo Nobuto; Kazuo Mochizuki
Journal:  Open Orthop J       Date:  2010-02-03

5.  LRP-1: a new modulator of cytoskeleton dynamics and adhesive complex turnover in cancer cells.

Authors:  Stéphane Dedieu; Benoit Langlois
Journal:  Cell Adh Migr       Date:  2008 Apr-May       Impact factor: 3.405

6.  Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1.

Authors:  Y Bertrand; J-C Currie; J Poirier; M Demeule; A Abulrob; D Fatehi; D Stanimirovic; H Sartelet; J-P Castaigne; R Béliveau
Journal:  Br J Cancer       Date:  2011-10-25       Impact factor: 7.640

7.  Verification and characterization of an alternative low density lipoprotein receptor-related protein 1 splice variant.

Authors:  Marlen Kolb; Susanne Kurz; Angelika Schäfer; Klaus Huse; Andreas Dietz; Gunnar Wichmann; Gerd Birkenmeier
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

8.  Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma.

Authors:  Ying Li; Xuemin Zheng; Min Gong; Jianning Zhang
Journal:  Oncotarget       Date:  2016-11-29

9.  Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.

Authors:  László Herszényi; Fabio Farinati; Romilda Cardin; Gábor István; László D Molnár; István Hritz; Massimo De Paoli; Mario Plebani; Zsolt Tulassay
Journal:  BMC Cancer       Date:  2008-07-10       Impact factor: 4.430

Review 10.  The Matricellular Receptor LRP1 Forms an Interface for Signaling and Endocytosis in Modulation of the Extracellular Tumor Environment.

Authors:  Bart Van Gool; Stéphane Dedieu; Hervé Emonard; Anton J M Roebroek
Journal:  Front Pharmacol       Date:  2015-11-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.